4//SEC Filing
Ross Leonard S 4
Accession 0000899243-18-031698
CIK 0001314102other
Filed
Dec 25, 7:00 PM ET
Accepted
Dec 26, 4:06 PM ET
Size
9.3 KB
Accession
0000899243-18-031698
Insider Transaction Report
Form 4
Ross Leonard S
Corporate Controller
Transactions
- Tax Payment
Common Stock
2018-12-22$1.65/sh−18,522$30,561→ 76,187 total - Exercise/Conversion
Restricted stock units
2018-12-22−62,892→ 0 total→ Common Stock (62,892 underlying) - Exercise/Conversion
Common Stock
2018-12-22+62,892→ 94,709 total
Footnotes (4)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units.
- [F3]Reflects the last reported sale price for the Registrant's shares of common stock on the Nasdaq Global Market on December 21, 2018.
- [F4]On December 22, 2017, the reporting person was granted 62,892 restricted stock units, vesting in full on the first anniversary of the grant date.
Documents
Issuer
EyePoint Pharmaceuticals, Inc.
CIK 0001314102
Entity typeother
Related Parties
1- filerCIK 0001458753
Filing Metadata
- Form type
- 4
- Filed
- Dec 25, 7:00 PM ET
- Accepted
- Dec 26, 4:06 PM ET
- Size
- 9.3 KB